[HTML][HTML] Pharmacokinetic drug-drug interaction and their implication in clinical management

C Palleria, A Di Paolo, C Giofrè, C Caglioti… - Journal of research in …, 2013 - ncbi.nlm.nih.gov
Drug-drug interactions (DDIs) are one of the commonest causes of medication error in
developed countries, particularly in the elderly due to poly-therapy, with a prevalence of 20 …

Methadone—metabolism, pharmacokinetics and interactions

A Ferrari, CPR Coccia, A Bertolini, E Sternieri - Pharmacological research, 2004 - Elsevier
The pharmacokinetics of methadone varies greatly from person to person; so, after the
administration of the same dose, considerably different concentrations are obtained in …

Role of cytochrome P450 in drug interactions

Z Bibi - Nutrition & metabolism, 2008 - Springer
Drug-drug interactions have become an important issue in health care. It is now realized that
many drug-drug interactions can be explained by alterations in the metabolic enzymes that …

Cardiovascular adverse effects of antipsychotic drugs

NA Buckley, P Sanders - Drug Safety, 2000 - Springer
Minor cardiovascular adverse effects from antipsychotic drugs are extremely common. They
include effects such as postural hypotension and tachycardia due to anticholinergic or α 1 …

Management of the adverse effects of clozapine

CR Young, MB Bowers Jr, CM Mazure - Schizophrenia Bulletin, 1998 - academic.oup.com
Clozapine has been found to be superior to traditional neuroleptics in the treatment of
refractory schizophrenia and is increasingly being used to treat schizophrenia, affective …

Interindividual variability of methadone response: impact of genetic polymorphism

Y Li, JP Kantelip, PG Schieveen, S Davani - Molecular diagnosis & therapy, 2008 - Springer
Methadone, an opioid analgesic, is used clinically in pain therapy as well as for substitution
therapy in opioid addiction. It has a large interindividual variability in response and a narrow …

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

JS Markowitz, KS Patrick - Clinical pharmacokinetics, 2001 - Springer
The psychostimulants methylphenidate, amphetamine and pemoline are among the most
common medications used today in child and adolescent psychiatry for the treatment of …

Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system

E Tanaka, S Hisawa - Journal of clinical pharmacy and …, 1999 - Wiley Online Library
Psychotherapeutic drugs (antipsychotics and antidepressants) are widely used for treating
anxiety. Many psychotherapeutic drugs are metabolized mainly by cytochrome P450 (CYP) …

[HTML][HTML] Drug-drug interactions in polypharmacy patients: The impact of renal impairment

B Papotti, C Marchi, MP Adorni, F Potì - Current research in pharmacology …, 2021 - Elsevier
Chronic kidney disease (CKD) is a long-term condition characterized by a gradual loss of
kidney functions, usually accompanied by other comorbidities including cardiovascular …

The hypertensive dental patient

BC Muzyka, M Glick - The Journal of the American Dental Association, 1997 - Elsevier
The dental team plays an integral role in safeguarding the general health of patients. Dental
health care workers should be able to recognize risk factors associated with hypertension …